Cinnamaldehyde in diabetes: A review of pharmacology, pharmacokinetics and safety

Pharmacological Research

Volumn 122, Issue , 2017, Pages 78-89

  Zhu, Ruyuan ^a   Liu, Haixia ^a   Liu, Chenyue ^a   Wang, Lili ^a   Ma, Rufeng ^a   Chen, Beibei ^a   Li, Lin ^a   Niu, Jianzhao ^a   Fu, Min ^b   Zhang, Dongwei ^a   Gao, Sihua ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Cinnamaldehyde; Diabetes; Obesity; Pharmacokinetics; Pharmacology; Safety

Indexed keywords

ADENYLATE KINASE; AMYLASE; CINNAMALDEHYDE; CINNAMIC ACID; CINNAMYL ALCOHOL; GHRELIN; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE PHOSPHATASE 1B; RETINOL BINDING PROTEIN 4; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NRF2; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; ACROLEIN; ANTIDIABETIC AGENT;

ACUTE TOXICITY; ADIPOSE TISSUE; ANTIDIABETIC ACTIVITY; AREA UNDER THE CURVE; BIOLOGICAL ACTIVITY; DIABETES MELLITUS; DRUG EFFECT; DRUG SAFETY; GASTROINTESTINAL TRACT; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HUMAN; HYPOTHALAMUS; INSULIN SENSITIVITY; KIDNEY; LIVER; LIVER TOXICITY; LUNG TOXICITY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PANCREAS; PHYTOCHEMISTRY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SKIN SENSITIZATION; STOMACH EMPTYING; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CHEMISTRY; CINNAMOMUM ZEYLANICUM; DRUG EFFECTS; INSULIN RESISTANCE; LIPID METABOLISM; METABOLISM;

ACROLEIN; ANIMALS; CINNAMOMUM ZEYLANICUM; DIABETES MELLITUS; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LIPID METABOLISM; SIGNAL TRANSDUCTION;

EID: 85020129944     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2017.05.019     Document Type: Review

References (122)

1. Zhou, M., Chen, Z., Shen, S., Recent advanceson cinnamaldehyde. J. Econ. Anim. 19 (2015), 1–5.
2. Khare, P., Jagtap, S., Jain, Y., Baboota, R.K., Mangal, P., Boparai, R.K., Bhutani, K.K., Sharma, S.S., Premkumar, L.S., Kondepudi, K.K., Chopra, K., Bishnoi, M., Cinnamaldehyde supplementation prevents fasting-induced hyperphagia, lipid accumulation, and inflammation in high-fat diet-fed mice. Biofactors 42 (2016), 201–211.
3. Ma, R., Zhu, R., Wang, L., Guo, Y., Liu, C., Liu, H., Liu, F., Li, H., Li, Y., Fu, M., Zhang, D., Diabetic osteoporosis: a review of its traditional chinese medicinal use and clinical and preclinical research. Evide. Based Complement. Alter. Med.: eCAM, 2016, 2016, 3218313.
4. Dumas, J.P.E., Organic chemistry research −on cinnamon oil, the hippuric acid and sebacic acid. Annales de chimie et de physique 57 (1834), 305–334.
5. Chiozza, L., Sur la production artificielle de ĺessence de cannelle [on the artificial production of cinnamon oil]. Comptes rendus (in French) 42 (1856), 222–227.
6. Subash Babu, P., Prabuseenivasan, S., Ignacimuthu, S., Cinnamaldehyde–a potential antidiabetic agent. Phytomedicine 14 (2007), 15–22.
7. Anand, P., Murali, K.Y., Tandon, V., Murthy, P.S., Chandra, R., Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenolpyruvate carboxykinase, and glut4 translocation in experimental diabetic rats. Chem. Biol. Interact. 186 (2010), 72–81.
8. Zhang, W., Xu, Y.C., Guo, F.J., Meng, Y., Li, M.L., Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus. Chin. Med. J.-Peking 121 (2008), 2124–2128.
9. Lee, S.C., Xu, W.X., Lin, L.Y., Yang, J.J., Liu, C.T., Chemical composition and hypoglycemic and pancreas-protective effect of leaf essential oil from indigenous cinnamon (cinnamomum osmophloeum kanehira). J. Agric. Food Chem. 61 (2013), 4905–4913.
10. El-Bassossy, H.M., Fahmy, A., Badawy, D., Cinnamaldehyde protects from the hypertension associated with diabetes. Food Chem. Toxicol. 49 (2011), 3007–3012.
11. Li, M., Xu, Y., Zhang, W., Effects of cinnamaldehyde on the expression levels of irs-1 and p85 alpha in gastrocnemius of type 2 diabetic rats. Med. J. Wuhan Univ., 30, 2009 (723–726 = 731).
12. Kumar, S., Vasudeva, N., Sharma, S., Gc-ms analysis and screening of antidiabetic, antioxidant and hypolipidemic potential of cinnamomum tamala oil in streptozotocin induced diabetes mellitus in rats. Cardiovasc. Diabetol., 11, 2012, 95.
13. Camacho, S., Michlig, S., de Senarclens-Bezencon, C., Meylan, J., Meystre, J., Pezzoli, M., Markram, H., le Coutre, J., Anti-obesity and anti-hyperglycemic effects of cinnamaldehyde via altered ghrelin secretion and functional impact on food intake and gastric emptying. Sci. Rep., 5, 2015, 7919.
14. Navarro, S.J., Trinh, T., Lucas, C.A., Ross, A.J., Waymire, K.G., Macgregor, G.R., The c57bl/6j mouse strain background modifies the effect of a mutation in bcl2l2. G3 2 (2012), 99–102.
15. Mekada, K., Abe, K., Murakami, A., Nakamura, S., Nakata, H., Moriwaki, K., Obata, Y., Yoshiki, A., Genetic differences among c57bl/6 substrains. Exp. Anim. 58 (2009), 141–149.
16. Kiselycznyk, C., Holmes, A., All (c57bl/6) mice are not created equal. Front. Neurosci., 5, 2011, 10.
17. Attane, C., Peyot, M.L., Lussier, R., Zhang, D., Joly, E., Madiraju, S.R., Prentki, M., Differential insulin secretion of high-fat diet-fed c57bl/6nn and c57bl/6nj mice: implications of mixed genetic background in metabolic studies. PLoS One, 11, 2016, e0159165.
18. Mugabo, Y., Zhao, S., Seifried, A., Gezzar, S., Al-Mass, A., Zhang, D., Lamontagne, J., Attane, C., Poursharifi, P., Iglesias, J., Joly, E., Peyot, M.L., Gohla, A., Madiraju, S.R., Prentki, M., Identification of a mammalian glycerol-3-phosphate phosphatase: role in metabolism and signaling in pancreatic beta-cells and hepatocytes. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), E430–439.
19. Mishra, A., Bhatti, R., Singh, A., Singh Ishar MP. Ameliorative effect of the cinnamon oil from cinnamomum zeylanicum upon early stage diabetic nephropathy. Planta Med. 76 (2010), 412–417.
20. Ping, H., Zhang, G., Ren, G., Antidiabetic effects of cinnamon oil in diabetic kk-ay mice. Food Chem. Toxicol. 48 (2010), 2344–2349.
21. Hafizur, R.M., Hameed, A., Shukrana, M., Raza, S.A., Chishti, S., Kabir, N., Siddiqui, R.A., Cinnamic acid exerts anti-diabetic activity by improving glucose tolerance in vivo and by stimulating insulin secretion in vitro. Phytomedicine 22 (2015), 297–300.
22. Bernardo, M.A., Silva, M.L., Santos, E., Moncada, M.M., Brito, J., Proenca, L., Singh, J., de Mesquita, M.F., Effect of cinnamon tea on postprandial glucose concentration. J. Diabetes Res., 2015, 2015, 913651.
23. Tamura, Y., Iwasaki, Y., Narukawa, M., Watanabe, T., Ingestion of cinnamaldehyde, a trpa1 agonist, reduces visceral fats in mice fed a high-fat and high-sucrose diet. J. Nutr. Sci. Vitaminol. 58 (2012), 9–13.
24. Davis, P.A., Yokoyama, W., Cinnamon intake lowers fasting blood glucose: meta-analysis. J. Med. Food 14 (2011), 884–889.
25. Im, K., Issac, A., Nm, J., Ninan, E., Maliakel, B., Kuttan, R., Effects of the polyphenol content on the anti-diabetic activity of cinnamomum zeylanicum extracts. Food Funct. 5 (2014), 2208–2220.
26. Lu, T., Sheng, H., Wu, J., Cheng, Y., Zhu, J., Chen, Y., Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in chinese patients with type 2 diabetes. Nutr. Res. 32 (2012), 408–412.
27. Hasanzade, F., Toliat, M., Emami, S.A., Emamimoghaadam, Z., The effect of cinnamon on glucose of type ii diabetes patients. J. Tradit. Complement. Med. 3 (2013), 171–174.
28. Bickers, D., Calow, P., Greim, H., Hanifin, J.M., Rogers, A.E., Saurat, J.H., Sipes, I.G., Smith, R.L., Tagami H, panel Re A toxicologic and dermatologic assessment of cinnamyl alcohol, cinnamaldehyde and cinnamic acid when used as fragrance ingredients. Food Chem. Toxicol. 43 (2005), 799–836.
29. Shreaz, S., Wani, W.A., Behbehani, J.M., Raja, V., Irshad, M., Karched, M., Ali, I., Siddiqi, W.A., Hun, L.T., Cinnamaldehyde and its derivatives, a novel class of antifungal agents. Fitoterapia 112 (2016), 116–131.
30. Zhao, H., Yuan, J., Yang, Q., Xie, Y., Cao, W., Wang, S., Cinnamaldehyde in a novel intravenous submicrometer emulsion: pharmacokinetics, tissue distribution, antitumor efficacy, and toxicity. J. Agric. Food Chem. 63 (2015), 6386–6392.
31. Shamansurova, Z., Tan, P., Ahmed, B., Pepin, E., Seda, O., Lavoie, J.L., Adipose tissue (p)rr regulates insulin sensitivity, fat mass and body weight. Mol. Metab. 5 (2016), 959–969.
32. Attane, C., Peyot, M.L., Lussier, R., Poursharifi, P., Zhao, S., Zhang, D., Morin, J., Pineda, M., Wang, S., Dumortier, O., Ruderman, N.B., Mitchell, G.A., Simons, B., Madiraju, S.R., Joly, E., Prentki, M., A beta cell atgl-lipolysis/adipose tissue axis controls energy homeostasis and body weight via insulin secretion in mice. Diabetologia 59 (2016), 2654–2663.
33. Li, Y.Q., Shrestha, Y.B., Chen, M., Chanturiya, T., Gavrilova, O., Weinstein, L.S., Gsalpha deficiency in adipose tissue improves glucose metabolism and insulin sensitivity without an effect on body weight. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 446–451.
34. Mulya, A., Brown, Kirwan J.P., beige adipose tissue: therapy for obesity and its comorbidities. Endocrinol. Metab. Clin. North Am. 45 (2016), 605–621.
35. Stanford, K.I., Goodyear, L.J., Exercise regulation of adipose tissue. Adipocyte 5 (2016), 153–162.
36. Watanabe, T., Terada, Y., Food compounds activating thermosensitive trp channels in asian herbal and medicinal foods. J. Nutr. Sci. Vitaminol. 61:Suppl (2015), S86–S88.
37. Mu, Q., Fang, X., Li, X., Zhao, D., Mo, F., Jiang, G., Yu, N., Zhang, Y., Guo, Y., Fu, M., Liu, J.L., Zhang, D., Gao, S., Ginsenoside rb1 promotes browning through regulation of ppargamma in 3t3-l1 adipocytes. Biochem. Biophys. Res. Commun. 466 (2015), 530–535.
38. Huang, B., Yuan, H.D., Kim, D.Y., Quan, H.Y., Chung, S.H., Cinnamaldehyde prevents adipocyte differentiation and adipogenesis via regulation of peroxisome proliferator-activated receptor-gamma (ppargamma) and amp-activated protein kinase (ampk) pathways. J. Agric. Food Chem. 59 (2011), 3666–3673.
39. Malandrino, M.I., Fucho, R., Weber, M., Calderon-Dominguez, M., Mir, J.F., Valcarcel, L., Escote, X., Gomez-Serrano, M., Peral, B., Salvado, L., Fernandez-Veledo, S., Casals, N., Vazquez-Carrera, M., Villarroya, F., Vendrell, J.J., Serra, D., Herrero, L., Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation. Am. J. Physiol. Endocrinol. Metab. 308 (2015), E756–769.
40. Klett, E.L., Chen, S., Edin, M.L., Li, L.O., Ilkayeva, O., Zeldin, D.C., Newgard, C.B., Coleman, R.A., Diminished acyl-coa synthetase isoform 4 activity in ins 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion. J. Biol. Chem. 288 (2013), 21618–21629.
41. Mugabo, Y., Zhao, S., Lamontagne, J., Al-Mass, A., Peyot, M.L., Corkey, B.E., Joly, E., Madiraju, S.R., Prentki, M., Metabolic fate of glucose and candidate signaling and excess-fuel detoxification pathways in pancreatic beta-cells. J. Biol. Chem., 2017.
42. Ellis, J.M., Li, L.O., Wu, P.C., Koves, T.R., Ilkayeva, O., Stevens, R.D., Watkins, S.M., Muoio, D.M., Coleman, R.A., Adipose acyl-coa synthetase-1 directs fatty acids toward beta-oxidation and is required for cold thermogenesis. Cell Metab. 12 (2010), 53–64.
43. Masamoto, Y., Kawabata, F., Fushiki, T., Intragastric administration of trpv1, trpv3, trpm8, and trpa1 agonists modulates autonomic thermoregulation in different manners in mice. Biosci. Biotechnol. Biochem. 73 (2009), 1021–1027.
44. Babu, P.V., Liu, D., Gilbert, E.R., Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J. Nutr. Biochem. 24 (2013), 1777–1789.
45. Bluher, M., Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance. Clin. Sci. 130 (2016), 1603–1614.
46. Chan, P.C., Hsiao, F.C., Chang, H.M., Wabitsch, M., Hsieh, P.S., Importance of adipocyte cyclooxygenase-2 and prostaglandin e2-prostaglandin e receptor 3 signaling in the development of obesity-induced adipose tissue inflammation and insulin resistance. FASEB J. 30 (2016), 2282–2297.
47. Yoshida, H., Watanabe, H., Ishida, A., Watanabe, W., Narumi, K., Atsumi, T., Sugita, C., Kurokawa, M., Naringenin suppresses macrophage infiltration into adipose tissue in an early phase of high-fat diet-induced obesity. Biochem. Biophys. Res. Commun. 454 (2014), 95–101.
48. Tateya, S., Tamori, Y., Kawaguchi, T., Kanda, H., Kasuga, M., An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice. Endocrinology 151 (2010), 971–979.
49. Sun, L.Q., Zhao, J., Zhang, T.T., Qu, L., Wang, X., Xue, B., Li, X.J., Mu, Y.M., Lu, J.M., Protective effects of salvianolic acid b on schwann cells apoptosis induced by high glucose. Neurochem. Res. 37 (2012), 996–1010.
50. Yang, S., Zhang, W., Zhen, Q., Gao, R., Du, T., Xiao, X., Wang, Z., Ge, Q., Hu, J., Ye, P., Zhu, Q., Li, Q., Impaired adipogenesis in adipose tissue associated with hepatic lipid deposition induced by chronic inflammation in mice with chew diet. Life Sci. 137 (2015), 7–13.
51. Gao, X., Li, K., Hui, X., Kong, X., Sweeney, G., Wang, Y., Xu, A., Teng, M., Liu, P., Wu, D., Carnitine palmitoyltransferase 1a prevents fatty acid-induced adipocyte dysfunction through suppression of c-jun n-terminal kinase. Biochem. J. 435 (2011), 723–732.
52. Lee, J.H., Lee, H.H., Ye, B.J., Lee-Kwon, W., Choi, S.Y., Kwon, H.M., Tonebp suppresses adipogenesis and insulin sensitivity by blocking epigenetic transition of ppargamma2. Sci. Rep., 5, 2015, 10937.
53. Sheng, X., Zhang, Y., Gong, Z., Huang, C., Zang, Y.Q., Improved insulin resistance and lipid metabolism by cinnamon extract through activation of peroxisome proliferator-activated receptors. PPAR Res., 2008, 2008, 581348.
54. Medagama, A.B., The glycaemic outcomes of cinnamon, a review of the experimental evidence and clinical trials. Nutr. J., 14, 2015, 108.
55. Li, J.E., Futawaka, K., Yamamoto, H., Kasahara, M., Tagami, T., Liu, T.H., Moriyama, K., Cinnamaldehyde contributes to insulin sensitivity by activating ppardelta, ppargamma, and rxr. Am. J. Chin. Med. 43 (2015), 879–892.
56. Nedachi, T., Kanzaki, M., Regulation of glucose transporters by insulin and extracellular glucose in c2c12 myotubes. Am. J. Physiol. Endocrinol. Metab. 291 (2006), E817–828.
57. DeFronzo, R.A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., Felber, J.P., The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30 (1981), 1000–1007.
58. Nikzamir, A., Palangi, A., Kheirollaha, A., Tabar, H., Malakaskar, A., Shahbazian, H., Fathi, M., Expression of glucose transporter 4 (glut4) is increased by cinnamaldehyde in c2c12 mouse muscle cells. Ir. Red Crescent Med. J., 16, 2014, e13426.
59. Gannon, N.P., Schnuck, J.K., Mermier, C.M., Conn, C.A., Vaughan, R.A., Trans-cinnamaldehyde stimulates mitochondrial biogenesis through pgc-1alpha and pparbeta/delta leading to enhanced glut4 expression. Biochimie 119 (2015), 45–51.
60. Nicholas, P.G., Schnuckc, J.K., Mermierd, C.M., Conne, C.A., Vaughanc, R.A., Trans-cinnamaldehyde stimulates mitochondrial biogenesis through pgc-1α and pparβ/δ leading to enhanced glut4 expression. Biochimie 119 (2015), 45–51.
61. Zhang, W., Xu, Y.C., Guo, F.J., Meng, Y., Li, M.L., Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus. Chin. Med. J. (Engl.) 121 (2008), 2124–2128.
62. Bandyopadhyay, G.K., Yu, J.G., Ofrecio, J., Olefsky, J.M., Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. Diabetes 54 (2005), 2351–2359.
63. Hesselink, M.K., Schrauwen-Hinderling, V., Schrauwen, P., Skeletal muscle mitochondria as a target to prevent or treat type 2 diabetes mellitus. Nat. Rev. Endocrinol. 12 (2016), 633–645.
64. Attane, C., Peyot, M.L., Lussier, R., Poursharifi, P., Zhao, S., Zhang, D., Morin, J., Pineda, M., Wang, S., Dumortier, O., Ruderman, N.B., Mitchell, G.A., Simons, B., Madiraju, S.R., Joly, E., Prentki, M., A beta cell atgl-lipolysis/adipose tissue axis controls energy homeostasis and body weight via insulin secretion in mice. Diabetologia, 2016.
65. Zhao, S., Mugabo, Y., Ballentine, G., Attane, C., Iglesias, J., Poursharifi, P., Zhang, D., Nguyen, T.A., Erb, H., Prentki, R., Peyot, M.L., Joly, E., Tobin, S., Fulton, S., Brown, J.M., Madiraju, S.R., Prentki, M., Alpha/beta-hydrolase domain 6 deletion induces adipose browning and prevents obesity and type 2 diabetes. Cell Rep. 14 (2016), 2872–2888.
66. Saraswathi, V., Ramnanan, C.J., Wilks, A.W., Desouza, C.V., Eller, A.A., Murali, G., Ramalingam, R., Milne, G.L., Coate, K.C., Edgerton, D.S., Impact of hematopoietic cyclooxygenase-1 deficiency on obesity-linked adipose tissue inflammation and metabolic disorders in mice. Metabolism 62 (2013), 1673–1685.
67. Ohaeri, O.C., Effect of garlic oil on the levels of various enzymes in the serum and tissue of streptozotocin diabetic rats. Biosci. Rep. 21 (2001), 19–24.
68. Mahfouz, M.H., Assiri, A.M., Mukhtar, M.H., Assessment of neutrophil gelatinase-associated lipocalin (ngal) and retinol-binding protein 4 (rbp4) in type 2 diabetic patients with nephropathy. Biomarker Insights 11 (2016), 31–40.
69. Jullig, M., Yip, S., Xu, A., Smith, G., Middleditch, M., Booth, M., Babor, R., Beban, G., Murphy, R., Lower fetuin-a, retinol binding protein 4 and several metabolites after gastric bypass compared to sleeve gastrectomy in patients with type 2 diabetes. PLoS One, 9, 2014, e96489.
70. Subash-Babu, P., Alshatwi, A.A., Ignacimuthu, S., Beneficial antioxidative and antiperoxidative effect of cinnamaldehyde protect streptozotocin-induced pancreatic beta-cells damage in wistar rats. Biomol. Ther. 22 (2014), 47–54.
71. Tong, J., Prigeon, R.L., Davis, H.W., Bidlingmaier, M., Kahn, S.E., Cummings, D.E., Tschop, M.H., D'Alessio, D., Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans. Diabetes 59 (2010), 2145–2151.
72. Nozawa, K., Kawabata-Shoda, E., Doihara, H., Kojima, R., Okada, H., Mochizuki, S., Sano, Y., Inamura, K., Matsushime, H., Koizumi, T., Yokoyama, T., Ito, H., Trpa1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 3408–3413.
73. Iwasaki, Y., Tanabe, M., Kobata, K., Watanabe, T., Trpa1 agonists-allyl isothiocyanate and cinnamaldehyde-induce adrenaline secretion. Biosci. Biotechnol. Biochem. 72 (2008), 2608–2614.
74. Koivisto, A., Hukkanen, M., Saarnilehto, M., Chapman, H., Kuokkanen, K., Wei, H., Viisanen, H., Akerman, K.E., Lindstedt, K., Pertovaara, A., Inhibiting trpa1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the trpa1 channel contributes to the pathogenesis of peripheral diabetic neuropathy. Pharmacol. Res. 65 (2012), 149–158.
75. Gomez, G., Han, S., Englander, E.W., Greeley, G.H. Jr., Influence of a long-term high-fat diet on ghrelin secretion and ghrelin-induced food intake in rats. Regul. Pept. 173 (2012), 60–63.
76. Chigr, F., Rachidi, F., Tardivel, C., Najimi, M., Moyse, E., Modulation of orexigenic and anorexigenic peptides gene expression in the rat dvc and hypothalamus by acute immobilization stress. Front. Cell. Neurosci., 8, 2014, 198.
77. Stengel, A., Tache, Y., Crf and urocortin peptides as modulators of energy balance and feeding behavior during stress. Front. Neurosci., 8, 2014, 52.
78. Gnudi, L., Coward, R.J., Long, D.A., Diabetic nephropathy: perspective on novel molecular mechanisms. ABBV Trends Endocrinol. Metab., 2016.
79. Chao, L.K., Chang, W.T., Shih, Y.W., Huang, J.S., Cinnamaldehyde impairs high glucose-induced hypertrophy in renal interstitial fibroblasts. Toxicol. Appl. Pharmacol. 244 (2010), 174–180.
80. Zheng, H., Whitman, S.A., Wu, W., Wondrak, G.T., Wong, P.K., Fang, D., Zhang, D.D., Therapeutic potential of nrf2 activators in streptozotocin-induced diabetic nephropathy. Diabetes 60 (2011), 3055–3066.
81. de Haan, J.B., Nrf2 activators as attractive therapeutics for diabetic nephropathy. Diabetes 60 (2011), 2683–2684.
82. Wang, F., Pu, C., Zhou, P., Wang, P., Liang, D., Wang, Q., Hu, Y., Li, B., Hao, X., Cinnamaldehyde prevents endothelial dysfunction induced by high glucose by activating nrf2. Cell. Physiol. Biochem. 36 (2015), 315–324.
83. Choi, B.-h., Kang, K.-S., Kwak, M.-K., Effect of redox modulating nrf2 activators on chronic kidney disease. Molecules 19 (2014), 12727–12759.
84. Crespo, M.C., Tome-Carneiro, J., Burgos-Ramos, E., Loria Kohen, V., Espinosa, M.I., Herranz, J., Visioli, F., One-week administration of hydroxytyrosol to humans does not activate phase ii enzymes. Pharmacol. Res. 95–96 (2015), 132–137.
85. Visioli, F., Xenobiotics and human health: a new view of their pharma-nutritional role. PharmaNutrition 3 (2015), 60–64.
86. Horr, S., Nissen, S., Managing hypertension in type 2 diabetes mellitus. Best Pract. Res. Clin. Endocrinol. Metab. 30 (2016), 445–454.
87. Gonzalez-Reyes, R.E., Aliev, G., Avila-Rodrigues, M., Barreto, G.E., Alterations in glucose metabolism on cognition: a possible link between diabetes and dementia. Curr. Pharm. Des. 22 (2016), 812–818.
88. Jawale, A., Datusalia, A.K., Bishnoi, M., Sharma, S.S., Reversal of diabetes-induced behavioral and neurochemical deficits by cinnamaldehyde. Phytomedicine 23 (2016), 923–930.
89. Okutan, L., Kongstad, K.T., Jager, A.K., Staerk, D., High-resolution alpha-amylase assay combined with high-performance liquid chromatography-solid-phase extraction-nuclear magnetic resonance spectroscopy for expedited identification of alpha-amylase inhibitors: proof of concept and alpha-amylase inhibitor in cinnamon. J. Agric. Food Chem. 62 (2014), 11465–11471.
90. Rios, J.L., Francini, F., Schinella, G.R., Natural products for the treatment of type 2 diabetes mellitus. Planta Med. 81 (2015), 975–994.
91. Fu, H., Park, J., Pei, D., Peptidyl aldehydes as reversible covalent inhibitors of protein tyrosine phosphatases. Biochemistry 41 (2002), 10700–10709.
92. Saifudin, A., Kadota, S., Tezuka, Y., Protein tyrosine phosphatase 1b inhibitory activity of indonesian herbal medicines and constituents of cinnamomum burmannii and zingiber aromaticum. J. Nat. Med. 67 (2013), 264–270.
93. Gonzalez-Rodriguez, A., Mas Gutierrez, J.A., Sanz-Gonzalez, S., Ros, M., Burks, D.J., Valverde, A.M., Inhibition of ptp1b restores irs1-mediated hepatic insulin signaling in irs2-deficient mice. Diabetes 59 (2010), 588–599.
94. Qian, M., Shan, Y., Guan, S., Zhang, H., Wang, S., Han, W., Structural basis of fullerene derivatives as novel potent inhibitors of protein tyrosine phosphatase 1b: insight into the inhibitory mechanism through molecular modeling studies. J. Chem. Inf. Model., 2016.
95. Sartorius, T., Peter, A., Schulz, N., Drescher, A., Bergheim, I., Machann, J., Schick, F., Siegel-Axel, D., Schurmann, A., Weigert, C., Haring, H.U., Hennige, A.M., Cinnamon extract improves insulin sensitivity in the brain and lowers liver fat in mouse models of obesity. PLoS One, 9, 2014, e92358.
96. Zhang, L.Q., Zhang, Z.G., Fu, Y., Xu, Y., Research progress of trans-cinnamaldehyde pharmacological effects. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China J. Chin. Materia Medi. 40 (2015), 4568–4572.
97. Zhao, H., Xie, Y., Yang, Q., Cao, Y., Tu, H., Cao, W., Wang, S., Pharmacokinetic study of cinnamaldehyde in rats by gc-ms after oral and intravenous administration. J. Pharm. Biomed. Anal. 89 (2014), 150–157.
98. Sapienza, P.P., Ikeda, G.J., Warr, P.I., Plummer, S.L., Dailey, R.E., Lin, C.S., Tissue distribution and excretion of 14c-labelled cinnamic aldehyde following single and multiple oral administration in male fischer 344 rats. Food Chem. Toxicol. 31 (1993), 253–261.
99. Peters, M.M., Caldwell, J., Studies on trans-cinnamaldehyde: 1The influence of dose size and sex on its disposition in the rat and mouse. Food Chem. Toxicol. 32 (1994), 869–876.
100. Yuan, J.H., Dieter, M.P., Bucher, J.R., Jameson, C.W., Toxicokinetics of cinnamaldehyde in f344 rats. Food Chem. Toxicol. 30 (1992), 997–1004.
101. Chen, Y., Ma, Y., Ma, W., Pharmacokinetics and bioavailability of cinnamic acid after oral administration of ramulus cinnamomi in rats. Eur. J. Drug Metab. Pharmacokinet. 34 (2009), 51–56.
102. Panel, R.E., Belsito, D., Bickers, D., Bruze, M., Calow, P., Dagli, M., Fryer, A.D., Greim, H., Miyachi, Y., Saurat, J.H., Sipes, I.G., A toxicologic and dermatologic assessment of cinnamyl phenylpropyl materials when used as fragrance ingredients. Food Chem. Toxicol. 49:Suppl. 2 (2011), S256–S267.
103. Hariri, M., Ghiasvand, R., Cinnamon and chronic diseases. Adv. Exp. Med. Biol. 929 (2016), 1–24.
104. Bubols, G.B., Vianna Dda, R., Medina-Remon, A., von Poser, G., Lamuela-Raventos, R.M., Eifler-Lima, V.L., Garcia, S.C., The antioxidant activity of coumarins and flavonoids. Mini Rev. Med. Chem. 13 (2013), 318–334.
105. Adisakwattana, S., Cinnamic acid and its derivatives: mechanisms for prevention and management of diabetes and its complications. Nutrients, 9, 2017.
106. Prasad, S.N., Bharath, M.M., Muralidhara Neurorestorative effects of eugenol, a spice bioactive: evidence in cell model and its efficacy as an intervention molecule to abrogate brain oxidative dysfunctions in the streptozotocin diabetic rat. Neurochem. Int. 95 (2016), 24–36.
107. Cao, H., Polansky, M.M., Anderson, R.A., Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3t3-l1 adipocytes. Arch. Biochem. Biophys. 459 (2007), 214–222.
108. Peng, X., Cheng, K.W., Ma, J., Chen, B., Ho, C.T., Lo, C., Chen, F., Wang, M., Cinnamon bark proanthocyanidins as reactive carbonyl scavengers to prevent the formation of advanced glycation endproducts. J. Agric. Food Chem. 56 (2008), 1907–1911.
109. Luo, Q., Wang, S.M., Lu, Q., Luo, J., Cheng, Y.X., Identification of compounds from the water soluble extract of cinnamomum cassia barks and their inhibitory effects against high-glucose-induced mesangial cells. Molecules 18 (2013), 10930–10943.
110. Dugoua, J.J., Seely, D., Perri, D., Cooley, K., Forelli, T., Mills, E., Koren, G., From type 2 diabetes to antioxidant activity: a systematic review of the safety and efficacy of common and cassia cinnamon bark. Can. J. Physiol. Pharmacol. 85 (2007), 837–847.
111. Gowder, S.J.T., Safety assessment of food flavor −cinnamaldehyde. Biosafety, 2014, 3.
112. Hooth, M.J., Sills, R.C., Burka, L.T., Haseman, J.K., Witt, K.L., Orzech, D.P., Fuciarelli, A.F., Graves, S.W., Johnson, J.D., Bucher, J.R., Toxicology and carcinogenesis studies of microencapsulated trans-cinnamaldehyde in rats and mice. Food Chem. Toxicol. 42 (2004), 1757–1768.
113. Swales, N.J., Caldwell, J., Studies on trans-cinnamaldehyde ii: mechanisms of cytotoxicity in rat isolated hepatocytes. Toxicol. In Vitro 10 (1996), 37–42.
114. Sanyal, R., Darroudi, F., Parzefall, W., Nagao, M., Knasmuller, S., Inhibition of the genotoxic effects of heterocyclic amines in human derived hepatoma cells by dietary bioantimutagens. Mutagenesis 12 (1997), 297–303.
115. Mereto, E., Brambilla-Campart, G., Ghia, M., Martelli, A., Brambilla, G., Cinnamaldehyde-induced micronuclei in rodent liver. Mutat. Res. 322 (1994), 1–8.
116. Behar, R.Z., Luo, W., Lin, S.C., Wang, Y., Valle, J., Pankow, J.F., Talbot, P., Distribution, quantification and toxicity of cinnamaldehyde in electronic cigarette refill fluids and aerosols. Tob. Control, 2016.
117. Isaac-Renton, M., Li, M.K., Parsons, L.M., Cinnamon spice and everything not nice: many features of intraoral allergy to cinnamic aldehyde. Dermatitis 26 (2015), 116–121.
118. Olsen, R.V., Andersen, H.H., Moller, H.G., Eskelund, P.W., Arendt-Nielsen, L., Somatosensory and vasomotor manifestations of individual and combined stimulation of trpm8 and trpa1 using topical l-menthol and trans-cinnamaldehyde in healthy volunteers. Eur. J. Pain 18 (2014), 1333–1342.
119. Dearman, R.J., Hilton, J., Evans, P., Harvey, P., Basketter, D.A., Kimber, I., Temporal stability of local lymph node assay responses to hexyl cinnamic aldehyde. J. Appl. Toxicol.: JAT 18 (1998), 281–284.
120. Smith, C.K., Moore, C.A., Elahi, E.N., Smart, A.T., Hotchkiss, S.A., Human skin absorption and metabolism of the contact allergens, cinnamic aldehyde, and cinnamic alcohol. Toxicol. Appl. Pharmacol. 168 (2000), 189–199.
121. Karrow, N.A., Leffel, E.K., Guo, T.L., Zhang, L.X., McCay, J.A., Germolec, D.R., White, K.L. Jr., Dermal exposure to cinnamaldehyde alters lymphocyte subpopulations, number of interferon-gamma-producing cells, and expression of b7 costimulatory molecules and cytokine messenger rnas in auricular lymph nodes of b6c3f1 mice. Am. J. Contact Dermatol. 12 (2001), 6–17.
122. Neudecker, T., The genetic toxicology of cinnamaldehyde. Mutat. Res. 277 (1992), 173–185.